AQR Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-21,635
| Closed | -$3.27M | – | 2342 |
|
2022
Q3 | $3.27M | Buy |
21,635
+2,898
| +15% | +$438K | 0.01% | 989 |
|
2022
Q2 | $2.73M | Sell |
18,737
-2,344
| -11% | -$342K | 0.01% | 986 |
|
2022
Q1 | $2.5M | Sell |
21,081
-2,407
| -10% | -$285K | ﹤0.01% | 1072 |
|
2021
Q4 | $3.24M | Sell |
23,488
-5,195
| -18% | -$716K | 0.01% | 947 |
|
2021
Q3 | $3.98M | Buy |
28,683
+20,713
| +260% | +$2.88M | 0.01% | 870 |
|
2021
Q2 | $774K | Sell |
7,970
-12,057
| -60% | -$1.17M | ﹤0.01% | 1693 |
|
2021
Q1 | $1.37M | Sell |
20,027
-190
| -0.9% | -$13K | ﹤0.01% | 1408 |
|
2020
Q4 | $1.73M | Sell |
20,217
-5,270
| -21% | -$452K | ﹤0.01% | 1233 |
|
2020
Q3 | $1.66M | Buy |
25,487
+13,802
| +118% | +$897K | ﹤0.01% | 1192 |
|
2020
Q2 | $854K | Sell |
11,685
-14,685
| -56% | -$1.07M | ﹤0.01% | 1518 |
|
2020
Q1 | $897K | Buy |
+26,370
| New | +$897K | ﹤0.01% | 1381 |
|
2018
Q4 | – | Sell |
-5,815
| Closed | -$218K | – | 2392 |
|
2018
Q3 | $218K | Buy |
+5,815
| New | +$218K | ﹤0.01% | 2178 |
|